Comparison of the effects of xylazine and acetylpromazine maleate in the horse.

This research investigates the comparative effects of two sedative drugs, xylazine and acetylpromazine maleate, on horses. The study found that xylazine, especially when administered intravenously, provided superior sedative results without adverse impacts on the cardiovascular and respiratory systems, compared to acetylpromazine maleate.

Research Design and Methodology

• The researchers employed a 3-way Latin square design to compare the effects of the two drugs. A Latin square design is a type of experimental design used to minimize the influence of confounding variables on outcome measures.
• Xylazine was administered in two ways: intravenously at a dosage of 1.1 mg./kg, and intramuscularly at double the dosage, 2.2 mg./kg. Acetylpromazine maleate was given intravenously at a dosage of 0.66 mg./kg.
• Physiological responses were recorded and clinical observations were made to assess the impact of the drugs.

Key Findings

• Xylazine when given with atropine sulphate through intravenous administration exhibited superior sedative properties without negatively affecting the cardiovascular and respiratory systems of the horses.
• Both intravenous and intramuscular administrations of xylazine lead to satisfactory preanesthetic effects. They were used before the induction of anesthesia with either thiamylal sodium or a mix of thiamylal sodium and halothane.
• Horses treated with xylazine showed less respiratory depression and more cardiovascular stability than those treated with acetylpromazine maleate. Hence, xylazine appears to be a safer and more effective preanesthetic agent in horses compared to acetylpromazine maleate.

Implications

• The research findings have significant implications for the care and treatment of horses requiring anesthesia. Xylazine might be a safer and more effective sedative option than acetylpromazine maleate.
• It also suggests that the method of administration (intravenous vs. intramuscular) has an impact on the drug’s effectiveness. In the case of xylazine, intravenous administration seems to provide more stable, predictable results.